| 136041-100MG |
|
70223-77-7 |
1,1'-[(1S,2S)-1,2-Cyclohexanediylbis(methylene)]bis[1,1-diphenylphosphine]
≥98%,99%e.e.
|
100MG |
C32H34P2 |
|
|
|
| 136042-100MG |
|
70774-28-6 |
[(1R,2R)-1,2-Cyclohexanediylbis(methylene)]bis[diphenylphosphine]
≥98%,-
|
100MG |
C32H34P2 |
|
|
|
| 136040-500MG |
|
156517-64-5 |
(3S,4S)-3,4-Bis(diphenylphosphino)-1-(phenylmethyl)pyrrolidine
≥98%,99%e.e.
|
500MG |
C35H33NP2 |
|
|
|
| 136040-100MG |
|
156517-64-5 |
(3S,4S)-3,4-Bis(diphenylphosphino)-1-(phenylmethyl)pyrrolidine
≥98%,99%e.e.
|
100MG |
C35H33NP2 |
|
|
|
| 136039-500MG |
|
99135-95-2 |
(3R,4R)-3,4-Bis(diphenylphosphino)-1-(phenylmethyl)pyrrolidine
≥98%,-
|
500MG |
C35H33NP2 |
|
|
|
| 136039-100MG |
|
99135-95-2 |
(3R,4R)-3,4-Bis(diphenylphosphino)-1-(phenylmethyl)pyrrolidine
≥98%,-
|
100MG |
C35H33NP2 |
|
|
|
| 135985-500MG |
|
NA(Component:61478-29-3) |
(2S,4S)-4-(Diphenylphosphino)-2-[(diphenylphosphino)methyl]pyrrolidine Hydrochloride
≥98%,99%e.e.
|
500MG |
C29H29NP2·HCl |
|
|
|
| 135985-100MG |
|
NA(Component:61478-29-3) |
(2S,4S)-4-(Diphenylphosphino)-2-[(diphenylphosphino)methyl]pyrrolidine Hydrochloride
≥98%,99%e.e.
|
100MG |
C29H29NP2·HCl |
|
|
|
| 135984-500MG |
|
61478-28-2 |
(2S,4S)-4-(Diphenylphosphino)-2-[(diphenylphosphino)methyl]-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester
≥98%,-
|
500MG |
C34H37NO2P2 |
|
|
|
| 135984-100MG |
|
61478-28-2 |
(2S,4S)-4-(Diphenylphosphino)-2-[(diphenylphosphino)methyl]-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester
≥98%,-
|
100MG |
C34H37NO2P2 |
|
|
|
| 200336-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6S)?-?6-?oxido-?dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide
≥95%,99%e.e.
|
100MG |
C17H17F3NO5PS |
|
|
|
| 200335-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6R)?-?6-?oxido-?dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide
≥95%,99%e.e.
|
100MG |
C17H17F3NO5PS |
|
|
|
| 200334-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6S)?-?6-?oxido-?4,?8-bis(3,5-dichlorophenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide
≥95%,99%e.e.
|
100MG |
C29H21Cl4F3NO5PS |
|
|
|
| 200333-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6R)?-?6-?oxido-?4,?8-bis(3,5-dichlorophenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide
≥95%,99%e.e.
|
100MG |
C29H21Cl4F3NO5PS |
|
|
|
| 200332-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6S)?-?6-?oxido-?4,?8-diphenyldibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide
≥95%,99%e.e.
|
100MG |
C29H25F3NO5PS |
|
|
|
| 200331-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6R)?-?6-?oxido-?4,?8-diphenyldibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide
≥95%,99%e.e.
|
100MG |
C29H25F3NO5PS |
|
|
|
| 200330-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6S)?-?6-?oxido-?4,?8-di(2-naphthalenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide
≥95%,99%e.e.
|
100MG |
C37H29F3NO5PS |
|
|
|
| 200329-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6R)?-?6-?oxido-?4,?8-di(2-naphthalenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide
≥95%,99%e.e.
|
100MG |
C37H29F3NO5PS |
|
|
|
| 200328-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6S)?-?6-?oxido-?4,?8-bis(3,5-dimethylphenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide
≥95%,99%e.e.
|
100MG |
C33H33F3NO5PS |
|
|
|
| 200327-100MG |
|
NA |
1,?1,?1-?Trifluoro-?N-?[(6R)?-?6-?oxido-?4,?8-bis(3,5-dimethylphenyl)dibenzo[d,f][1,3,2]dioxaphosphepin-?6-?yl]?methanesulfonamide
≥95%,99%e.e.
|
100MG |
C33H33F3NO5PS |
|
|
|
